Who is sponsoring NCT06023901?

NCT06023901 is sponsored by Istanbul Medipol University Hospital.

What condition does NCT06023901 study?

NCT06023901 studies Periapical Periodontitis.

What drugs are being tested in NCT06023901?

Interventions: Apical periodontitis.

What is the status of NCT06023901?

NCT06023901 is currently COMPLETED.

Last reviewed 2026-02-27 · How we verify

The Importance of Prostaglandin and Nitric Oxide Synthesis in Apical Periodontitis

NCT06023901 NA COMPLETED

A total of 185 subjects were divided into three categories: AP group (n=85), CP group (n=50) and healthy control group (n=50). The AP group was divided into 3 subgroups according to abscess scoring (AS-PAI) based on the periapical index. The CP group was divided into 4 subgroups according to the periodontitis staging system (PSS). After recording the demographic and clinical characteristics of all participants, blood and gingival crevicular fluid (GCF) samples were taken. TNF-α, IL-10, PGE2 and NO levels were measured in these samples.

Details

Lead sponsor	Istanbul Medipol University Hospital
Phase	NA
Status	COMPLETED
Enrolment	185
Start date	Thu Jan 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Wed Aug 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Periapical Periodontitis

Interventions

Apical periodontitis

Countries

Turkey (Türkiye)